FDA Approved Drug For Treatment Of Anthrax

Dec. 21 | The U.S. Food and Drug Administration (FDA) approved raxibacumab of GlaxoSmithKline plc for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs and for prophylaxis...

Study Shows How H.plylori Causes Cell Death

Nov. 29 | Researchers have investigated out how the cancer-causing bacterium Helicobacter pylori  attacks a cell’s energy infrastructure, sparking a series of events in the cell that ultimately lead it to self-destruct. H. pylori are the only bacteria known...